Shares of La-Z-Boy Inc. (NYSE: LZB) surged more than 4% after Stifel Nicolaus upgraded its rating on the company to Buy from Hold with a price target of $10.
OpenTable, Inc. (NASDAQ: OPEN) rallied more than 2% after Bank of America/Merrill Lynch upgraded online restaurant reservation company to Buy from Neutral and upped its price target to $63 from $50.
Shares of Vistaprint N.V. (NASDAQ: VPRT) soared more than 7% on Wednesday on speculation that the printing company may be acquired.
Pacer International (NASDAQ: PACR) gained as much as 5% after Stephens & Co upgraded the stock to Overweight from Equalweight with a $9 price target.
Neuralstem, Inc. (AMEX: CUR) jumped more than 11% on Wednesday after it announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin a Phase I safety clinical trial for chronic spinal cord injury with its spinal cord stem cells. This multicenter Phase I safety trial will enroll a total of 16 long-term, or chronic, spinal cord injury patients, with an American Spinal Injury Association (ASIA) Grade A level of impairment, one-to-two years post-injury.
Disclosure: Author doesn't own any of the stocks discussed here.
